Two heterobivalent imaging agents targeting PSMA and integrin-αvβ3 surface markers, both overexpressed in certain tumor epithelium and/or neovasculature were synthesized and evaluated by Shallal et al. [184]. The gene discussed is FOLH1; the disease is neoplasm.